This month’s Drug Discovery Today Editor’s Choice brings you unique perspectives on the potential of nanomedicines and the associated regulatory landscape, from researchers across the globe. We highlight four nanotechnology-related reviews from Drug Discovery Today and related publications that discuss the emerging concepts in the development of targeted therapeutic and imaging nanodevices, their path to clinical translation, and how they are being viewed from a regulatory environment.
26 August, 2011